Shares of Novo Nordisk (NVO) slipped on Friday following a note from JPMorgan's Richard Vosser. Vosser warned that the pharmaceutical giant's third quarter results could show a slowing in sales of the company's blockbuster weight-loss drug Wegovy.

Market Domination Anchors Julie Hyman and Josh Lipton discuss the call in the video above.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Stephanie Mikulich.